ACS Clinical Research Program
PACES trial: Evaluating the effectiveness of eflornithine and sulindac in preventing colon adenomas(Comments Off)
The S0820 Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES) study seeks to determine whether two drugs that have shown early promise can significantly lower the risk of secondary colorectal polyp or cancer for these survivors.
This column addresses the efficacy of combining existing approaches with active therapeutic combinations to treat cancers of the stomach and esophagus.
Operative Standards for Cancer Surgery, developed by the ACS Clinical Research Program Cancer Care Standards Development Committee, provides evidence-based guidelines for oncologic resections.
A clinical trial is exploring whether limited resection should replace lobectomy as the gold standard for treatment of early-stage lung cancer.
The PROSPECT trial for individualized treatment is discussed in this month’s column as is the surgeon’s role in ensuring the success of this trial.
More in this category
- Colorectal cancer metastatic to the liver: Making the unresectable resectable
- QOL concerns in surgical patients: Assessment and intervention
- Treating metastatic prostate cancer now and in the future
- NCDB and ACS-CRP: Working together to develop risk-stratified strategies for surveillance
- SLN surgery for clinically node-positive breast cancer patients treated with neoadjuvant therapy
- Neoadjuvant cancer therapy: Benefitting patients and improving cancer care
- Patient quality of life: Vitally important
- Community-based physicians and hospitals need to participate in clinical trials
- Less invasive option for small hepatocellular carcinoma: Thermal ablation as first-line therapy?
- Patient-centered outcomes research: Is this really something new?
- Does altering diet affect progression of prostate cancer? The MEAL study
- American College of Surgeons Commission on Cancer Rapid Quality Reporting System: From quality measurement to quality improvement
- Improving cancer care through quality measures: Putting evidence to work with the CoC
- What is the appropriate extent of lymphadenectomy for bladder cancer?
- Are older adults adequately represented in surgical oncology trials?